Skip to main content

The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis

  • Chapter
  • First Online:
Cell Biology and Translational Medicine, Volume 12

Abstract

Rheumatoid arthritis as a common autoimmune inflammatory disorder with unknown etiology can affect 0.5–1% of adults in developed countries. It involves more than just the patient’s joints and can be accompanied by several comorbidities and affect cardiovascular, pulmonary, and some other systems of the human body. Although cytokine-mediated pathways are mentioned to have a central role in RA pathogenesis, adaptive and innate immune systems and intracellular signaling pathways all have important roles in this process. Non-steroidal anti-inflammatory drugs, glucocorticoids, conventional disease-modifying anti-rheumatic drugs, and biological agents are some mentioned medications used for RA. They are accompanied by some adverse effects and treatment failures which elucidates the needing for novel and more powerful therapeutic approaches. Stem cell-based therapies and their beneficial effects on therapeutic processes of different diseases have been founded so far. They can be an alternative and promising therapeutic approach for RA, too; due to their effects on immune responses of the disease. This review, besides some explanations about RA characteristics, addresses the outcome of the stem cell-based therapies including mesenchymal stem cell transplantation and hematopoietic stem cell transplantation for RA and explains their effects on the disease improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACPA:

Anti–Citrullinated Protein Antibody

Ad-MSCs:

Adipose-Derived Mesenchymal Stem Cells

ADSCs:

Adipose-Derived Stem Cells

AHSCT:

Autologous Hematopoietic Stem Cell Transplantation

Allo-HSCT:

Allogeneic Hematopoietic Stem Cell Transplantation

AP-1:

Activator Protein 1

APTC:

Antiplatelet Trialists Collaboration

BAFF:

B-cell Activating Factor

BM:

Bone Marrow

BM-MSCs:

Bone Marrow-MSCs

CCR7:

CC-Chemokine Receptor type 7

CD40L:

CD40 Ligand

CFA:

Complete Freund’s Adjuvant

CIA:

Collagen-Induced Arthritis

COX:

Cyclooxygenase

CXCR5:

Chemokine C-X-C Motif Receptor5

CYC:

Cyclophosphamide

DAS28:

Disease Activity Score 28

DMARDs:

Disease-Modifying Anti-Rheumatic Drugs

ESR:

Erythrocyte Sedimentation Rate

FLSs:

Fibroblast-Like Synoviocytes

Foxp3:

Forkhead box protein P3

G-CSF:

Granulocyte-Colony Stimulating Factor

GI:

Gastrointestinal

GM-CSF:

Granulocyte-Macrophage Colony-Stimulating Factor

GvHD:

Graft-versus-Host Disease

hAdMSCs:

human Adipose-derived Mesenchymal Stem Cells

haplo-SCT:

haplo-identical SCT

HDC:

High-Dose Chemotherapy

HLA:

Human Leukocyte Antigen

HSCs:

Hematopoietic Stem Cells

HSCT:

Hematopoietic Stem Cell Transplantation

hUCMSCs:

Human UC-MSCs

ICOS:

Inducible Costimulatory Molecule

IFN:

Interferon

IgG:

Immunoglobulin G

IL:

Interleukin

ILD:

Interstitial Lung Disease

iNOS:

inducible Nitric Oxide Synthase

JAK:

Janus Kinase

JIA:

Juvenile Idiopathic Arthritis

M-CSF:

Macrophage-Colony Stimulating Factor

MHC:

Major Histocompatibility Complex

MMPs:

Matrix Metalloproteinases

MPCs:

Mesenchymal Precursor Cells

MS:

Multiple Sclerosis

MSCs:

Mesenchymal Stem Cells

MSCT:

MSC Transplantation

MTX:

Methotrexate

NF-Κb:

Nuclear Factor Kappa B

NK:

Natural Killer

NLRs:

NOD-Like Receptors

NOD:

Non-Obese Diabetic

NOD:

Nucleotide-Binding Oligomerization Domain

NSAIDs:

Nonsteroidal Anti-Inflammatory Drugs

PBSCs:

peripheral blood stem cells

PBSCT:

Peripheral Blood Stem Cell Transplantation

PD-1:

Programmed Cell Death Protein 1

PGE2:

Prostaglandin E2

PI 3-kinase:

Phosphatidylinositol 3-Kinase

PPI:

Proton Pump Inhibitor

PTCL:

Peripheral T Cell Lymphoma

RA:

Rheumatoid Arthritis

RANKL:

Receptor Activator of Nuclear Factor κB Ligand

RF:

Rheumatoid Factor

rhTNFR:Fc:

recombinant human TNF Receptor:Fc Fusion Protein

RORγt:

RAR-related Orphan Receptor Gamma

SCT:

Stem Cell Transplantation

SDF-1:

Stromal Cell-Derived Factor-1

SLE:

Systemic Lupus Erythematosus

SS:

Sjögren’s Syndrome

T1D:

Type 1 Diabetes

Tfh:

T Follicular helper

TGFβ:

Transforming Growth Factor β

Th:

T helper

TLRs:

Toll-Like Receptors

TNF:

Tumor Necrosis Factor

Treg:

T regulatory cells

UCB:

Umbilical Cord Blood

UC-MSCs:

Umbilical Cord MSCs

VAS:

Visual Analog Scale

References

  • Abasolo L, Tobías A, Leon L, Carmona L, Fernandez-Rueda JL, Rodriguez AB, Fernandez-Gutierrez B, Jover JA (2013) Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. Reumatología Clínica (English Edition) 9(4):226–228

    Article  Google Scholar 

  • Abdelmawgoud H, Saleh A (2018) Anti-inflammatory and antioxidant effects of mesenchymal and hematopoietic stem cells in a rheumatoid arthritis rat model. Adv Clin Exp Med 27(7):873–880

    Article  PubMed  Google Scholar 

  • Abughanam G, Elkashty OA, Liu Y, Bakkar MO, Tran SD (2019) Mesenchymal stem cells extract (MSCsE)-based therapy alleviates xerostomia and Keratoconjunctivitis sicca in Sjogren’s syndrome-like disease. Int J Mol Sci 20(19):4750

    Article  CAS  PubMed Central  Google Scholar 

  • Aghayan HR, Soleimani M, Goodarzi P, Norouzi-Javidan A, Emami-Razavi SH, Larijani B, Arjmand B (2014) Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci 19(5):465–471

    PubMed  PubMed Central  Google Scholar 

  • Aghayan HR, Payab M, Mohamadi-Jahani F, Aghayan SS, Larijani B, Arjmand B (2020) GMP-compliant production of human placenta-derived mesenchymal stem cells. In: Methods in molecular biology. Springer, New York

    Google Scholar 

  • Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360–1372

    Article  PubMed  Google Scholar 

  • Álvaro-Gracia JM, Jover JA, García-Vicuña R, Carreño L, Alonso A, Marsal S, Blanco F, Martínez-Taboada VM, Taylor P, Martín-Martín C (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis 76(1):196–202

    Article  PubMed  CAS  Google Scholar 

  • Arbeláez-Cortés Á, Bejarano-Pineda L, Toro-Gutiérrez CE (2013) Autologous peripheral hematopoietic stem cell transplantation. Autoimmunity: from Bench to Bedside [Internet]. El Rosario University Press

    Google Scholar 

  • Arjmand B, Goodarzi P, Mohamadi-Jahani F, Falahzadeh K, Larijani B (2017) Personalized regenerative medicine. Acta Med Iran 55(3):144–149

    PubMed  Google Scholar 

  • Arjmand B, Goodarzi P, Aghayan HR, Payab M, Rahim F, Alavi-Moghadam S, Mohamadi-Jahani F, Larijani B (2019) Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in type 1 diabetic mice model. Front Endocrinol (Lausanne) 10:761

    Article  Google Scholar 

  • Askari A, Moskowitz RW, Goldberg VM (1974) Subcutaneous rheumatoid nodules and serum rheumatoid factor without arthritis. JAMA 229(3):319–320

    Article  CAS  PubMed  Google Scholar 

  • Atoui A, El Labban M, Ghaoui N, El Darsa H, El Cheikh J, Bazarbachi A (2019) Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma. Bone Marrow Transplant 55:979–981

    Google Scholar 

  • Baharlou R, Ahmadi-Vasmehjani A, Faraji F, Atashzar MR, Khoubyari M, Ahi S, Erfanian S, Navabi S-S (2017) Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: regulatory effects on peripheral blood mononuclear cells activation. Int Immunopharmacol 47:59–69

    Article  CAS  PubMed  Google Scholar 

  • Barker N (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15(1):19–33

    Article  CAS  PubMed  Google Scholar 

  • Bergot A-S, Giri R, Thomas R (2020) The microbiome and rheumatoid arthritis. Best Pract Res Clin Rheumatol:101497. https://doi.org/10.1016/j.berh.2020.101497

  • Berthelot J-M, Le Goff B, Maugars Y (2019) Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions? Arthritis Res Ther 21(1):239

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bickham K, Kivitz AJ, Mehta A, Frontera N, Shah S, Stryszak P, Popmihajlov Z, Peloso PM (2016) Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC Musculoskelet Disord 17(1):331

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Biehl JK, Russell B (2009) Introduction to stem cell therapy. J Cardiovasc Nurs 24(2):98

    Article  PubMed  PubMed Central  Google Scholar 

  • Brignier AC, Gewirtz AM (2010) Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125(2):S336–S344

    Article  PubMed  Google Scholar 

  • Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, Graziano F, Mineishi S, Brush M, Fishman M (1999a) Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 42(11):2281–2285

    Article  CAS  PubMed  Google Scholar 

  • Burt RK, Traynor A, Burns W (1999b) Hematopoietic stem cell transplantation of multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. In: Advances in allogeneic hematopoietic stem cell transplantation. Springer, Boston, pp 157–184

    Chapter  Google Scholar 

  • Burt RK, Barr W, Oyama Y, Traynor A, Slavin S (2001) Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis. J Rheumatol Suppl 64:42–48

    CAS  PubMed  Google Scholar 

  • Caglayan S, Ahrens TD, Cieślar-Pobuda A, Staerk J (2019) Chapter 3 Modern ways of obtaining stem cells. In: Stem cells and biomaterials for regenerative medicine. Elsevier, pp 17–36

    Google Scholar 

  • Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347(26):2104–2110

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor R (2008) Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. NIHR Health Technology Assessment programme: Executive Summaries, NIHR Journals Library

    Google Scholar 

  • Clark K, Zhang S, Barthe S, Kumar P, Pivetti C, Kreutzberg N, Reed C, Wang Y, Paxton Z, Farmer D (2019) Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cell 8(12):1497

    Article  CAS  Google Scholar 

  • Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(3):S2

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Cush JJ, Kavanaugh A, Weinblatt ME (2010) Rheumatoid arthritis: early diagnosis and treatment. Professional Communications, West Islip

    Google Scholar 

  • De Bari C (2015) Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis Res Ther 17(1):113

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • de Oliveira PG, Farinon M, Sanchez-Lopez E, Miyamoto S, Guma M (2019) Fibroblast-like Synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Front Immunol 10:1743

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Edwards JC, Szczepański L, Szechiński J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581

    Article  CAS  PubMed  Google Scholar 

  • El Qashty RMN, Mohamed NN, Radwan LRS, Ibrahim FMM (2018) Effect of bone marrow mesenchymal stem cells on healing of temporomandibular joints in rats with induced rheumatoid arthritis. Eur J Oral Sci 126(4):272–281

    Article  PubMed  CAS  Google Scholar 

  • El-Jawhari J, El-Sherbiny Y, Jones E, McGonagle D (2014) Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM Int J Med 107(7):505–514

    Article  CAS  Google Scholar 

  • Farquhar H, Vassallo R, Edwards AL, Matteson EL (2019) Pulmonary complications of rheumatoid arthritis. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers, New York, NY

    Google Scholar 

  • Faustman DL, Davis M (2010) Stem cells in the spleen: therapeutic potential for Sjogren’s syndrome, type I diabetes, and other disorders. Int J Biochem Cell Biol 42(10):1576–1579

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183–196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121(10):S9–S14

    Article  PubMed  PubMed Central  Google Scholar 

  • Ge F, Lin H, Li Z, Chang T (2019) Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 40(3):479–487

    Article  PubMed  Google Scholar 

  • Goodarzi P, Aghayan HR, Soleimani M, Norouzi-Javidan A, Mohamadi-Jahani F, Jahangiri S, Emami-Razavi SH, Larijani B, Arjmand B (2014) Stem cell therapy for treatment of epilepsy. Acta Med Iran 52(9):651–655

    PubMed  Google Scholar 

  • Goodarzi P, Aghayan HR, Larijani B, Soleimani M, Dehpour AR, Sahebjam M, Ghaderi F, Arjmand B (2015) Stem cell-based approach for the treatment of Parkinson’s disease. Med J Islam Repub Iran 29:168

    PubMed  PubMed Central  Google Scholar 

  • Goodarzi P, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Mohamadi-Jahani F, Ranjbaran N, Payab M, Falahzadeh K, Mousavi M, Arjmand B (2018) Mesenchymal stem cells-derived exosomes for wound regeneration. Adv Exp Med Biol 1119:119–131

    Article  CAS  PubMed  Google Scholar 

  • Goodarzi P, Alavi-Moghadam S, Payab M, Larijani B, Rahim F, Gilany K, Bana N, Tayanloo-Beik A, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019a) Metabolomics analysis of mesenchymal stem cells. Int J Mol Cell Med 8(Suppl1):30–40

    CAS  PubMed  PubMed Central  Google Scholar 

  • Goodarzi P, Falahzadeh K, Aghayan H, Payab M, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Adibi H, Gilany K, Arjmand B (2019b) Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country. Cell Tissue Bank 20(1):11–24

    Article  PubMed  Google Scholar 

  • Goodarzi P, Payab M, Alavi-Moghadam S, Larijani B, Rahim F, Bana N, Sarvari M, Adibi H, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019c) Development and validation of Alzheimer’s disease animal model for the purpose of regenerative medicine. Cell Tissue Bank 20(2):141–151

    Article  PubMed  Google Scholar 

  • Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J (2018) Adult stem cells for regenerative therapy. Prog Mol Biol Transl Sci (Elsevier) 160:1–22

    Article  CAS  Google Scholar 

  • Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Östör AJ (2011) Non-infectious pulmonary complications of newer biological agents for rheumatic diseases—a systematic literature review. Rheumatology 50(12):2297–2305

    Article  PubMed  Google Scholar 

  • Harris HE, Tweedie F, White M, Samson K (2016) How to motivate patients with rheumatoid arthritis to quit smoking. J Rheumatol 43(4):691–698

    Article  PubMed  Google Scholar 

  • Hatzimichael E, Tuthill M (2010) Hematopoietic stem cell transplantation. Stem Cells Cloning Adv Appl 3:105

    Google Scholar 

  • Henriksson K, Jörgensen L, From J, Stratelis G (2013) FRI0539 Patient reported adherence to co-prescribed ppi gastro protection treatment in osteoarthritis, rheumatoid arthritis or ankylosing spondylitis patients using nsaid. Ann Rheum Dis 72(Suppl 3):A557–A557

    Article  Google Scholar 

  • Hirohata S, Yanagida T, Nakamura H, Yoshino S, Tomita T, Ochi T (2000) Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals. Rheumatol Int 19(4):153–159

    Article  CAS  PubMed  Google Scholar 

  • Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S i, Tomita T, Ochi T (2001) Induction of fibroblast-like cells from CD34+ progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 70(3):413–421

    CAS  PubMed  Google Scholar 

  • Irwin MR, Olmstead R, Carrillo C, Sadeghi N, FitzGerald JD, Ranganath VK, Nicassio PM (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537–543

    Article  PubMed  PubMed Central  Google Scholar 

  • Johansson CB, Svensson M, Wallstedt L, Janson AM, Frisén J (1999) Neural stem cells in the adult human brain. Exp Cell Res 253(2):733–736

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen C, Noel D, Apparailly F, Sany J (2001) Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 60(4):305–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joseph R, Wang Y, Zhong L, Palecek SP, Nagy K, Agha-Mohammadi S (2020) Advances in induced pluripotent stem cell. In: Advances in induced pluripotent stem cell, p 185

    Google Scholar 

  • Jung SY (2018) Adult stem cell treatment for rheumatoid arthritis. J Rheum Dis 25(3):158–168

    Article  Google Scholar 

  • Kafaja S, Segal K, Skerrett D, Itescu S, Furst D (2017) FRI0220 Allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis. Ann Rheum Dis 76(Suppl 2):566–567

    Google Scholar 

  • Källberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L, Alfredsson L, E. S. Group (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70(3):508–511

    Article  PubMed  Google Scholar 

  • Karamini A, Bakopoulou A, Andreadis D, Gkiouras K, Kritis A (2020) Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev 16:276–287

    Google Scholar 

  • Kartiko BH, Siswanto FM, Purwata TE (2017) Mesenchymal stem cell (MSC) as a potential cell therapy for immune related disease. Bali Med J 6(1):38–43

    Article  Google Scholar 

  • Khaddour K, Mewawalla P (2019) Hematopoietic stem cell transplantation. StatPearls [internet]. StatPearls Publishing

    Google Scholar 

  • Kiatpongsan S, Tannirandorn Y, Virutamasen P (2006) Introduction to stem cell medicine. J Med Assoc Thail 89(1):111

    Google Scholar 

  • Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY (2007) Up-regulation of stromal cell–derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L–CD40 interaction. Arthritis Rheum 56(4):1076–1086

    Article  CAS  PubMed  Google Scholar 

  • Kim J-H, Lee YT, Oh K, Cho J, Lee D-S, Hwang Y-i (2014) Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice. Cell Immunol 292(1–2):94–101

    Article  CAS  PubMed  Google Scholar 

  • Kragstrup TW, Andersen T, Heftdal LD, Hvid M, Gerwien J, Sivakumar P, Taylor PC, Senolt L, Deleuran B (2018) The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis. Front Immunol 9:2226

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lampropoulos C, Orfanos P, Bournia V, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis M, Tzioufas A, Moutsopoulos H, Vlachoyiannopoulos P (2015) Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol 33(2):216–224

    PubMed  Google Scholar 

  • Larijani B, NASLI EE, Amini P, Nikbin B, Alimoghaddam K, Amiri S, Malekzadeh R, Mojahed YN, Ghodsi M, Dowlati Y (2012) Stem cell therapy in treatment of different diseases. Acta Med Iran 50(2):79–96

    PubMed  Google Scholar 

  • Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N, Abedi M, Arabi M, Adibi H, Gilany K, Arjmand B (2019a) Metabolomics and cell therapy in diabetes mellitus. Int J Mol Cell Med 8(Suppl1):41–48

    CAS  PubMed  PubMed Central  Google Scholar 

  • Larijani B, Goodarzi P, Payab M, Tayanloo-Beik A, Sarvari M, Gholami M, Gilany K, Nasli-Esfahani E, Yarahmadi M, Ghaderi F, Arjmand B (2019b) The design and application of an appropriate Parkinson’s disease animal model in regenerative medicine. Adv Exp Med Biol 50:79–96

    Google Scholar 

  • Larijani B, Foroughi Heravani N, Alavi-Moghadam S, Goodarzi P, Rezaei-Tavirani M, Payab M, Gholami M, Razi F, Arjmand B (2020) Cell therapy targets for autism Spectrum disorders: hopes, challenges and future directions. Adv Exp Med Biol

    Google Scholar 

  • Lazzerini PE, Capecchi PL, Laghi-Pasini F (2017) Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 38(22):1717–1727

    CAS  PubMed  Google Scholar 

  • Lee YH, Seo YH (2018) SAT0167 Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials. Ann Rheum Dis 77(Suppl 2):944–944

    Google Scholar 

  • Lee H-H, Song I-H, Friedrich M, Gauliard A, Detert J, Röwert J, Audring H, Kary S, Burmester G-R, Sterry W, Worm M (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists. Br J Dermatol 156(3):486–491

    Article  CAS  PubMed  Google Scholar 

  • Leung PSC, Shuai Z, Liu B, Shu SA, Sun L (2017) Stem cell therapy in the treatment of rheumatic diseases and application in the treatment of systemic lupus erythematosus. In: Mina-Osorio P (ed) Next-generation therapies and technologies for immune-mediated inflammatory diseases. Springer International Publishing, Cham, pp 167–198

    Chapter  Google Scholar 

  • Lipsky PE, van der Heijde DM, Clair EWS, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343(22):1594–1602

    Article  CAS  PubMed  Google Scholar 

  • Littlejohn EA, Monrad SU (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care 45(2):237–255

    Article  PubMed  Google Scholar 

  • Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z (2010) Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12(6):R210

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, Feng X, Gao X, Shi S, Chen W, Sun L (2015) Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep 5(1):12777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luque-Campos N, Contreras-López RA, Paredes-Martínez MJ, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P (2019) Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol 10:8459281

    Article  CAS  Google Scholar 

  • Ma X, Xu S (2013) TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 1(2):177–184

    Article  CAS  PubMed  Google Scholar 

  • Ma D, Xu K, Zhang G, Liu Y, Gao J, Tian M, Wei C, Li J, Zhang L (2019) Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol 74:105687

    Article  CAS  PubMed  Google Scholar 

  • Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 39:16–29

    Article  CAS  PubMed  Google Scholar 

  • Mattila K, Buttgereit F, Tuominen R (2014) Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis. Rheumatol Int 34(12):1751–1758

    Article  PubMed  PubMed Central  Google Scholar 

  • McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219

    Article  CAS  PubMed  Google Scholar 

  • McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nat Rev Rheumatol 12(1):63

    Article  CAS  PubMed  Google Scholar 

  • Mellado M, Martínez-Muñoz L, Cascio G, Lucas P, Pablos JL, Rodríguez-Frade JM (2015) T cell migration in rheumatoid arthritis. Front Immunol 6:384

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mikkola HK, Orkin SH (2006) The journey of developing hematopoietic stem cells. Development 133(19):3733–3744

    Article  CAS  PubMed  Google Scholar 

  • Moore J, Milliken S, David JB, Brooks P (2001) Peripheral blood stem cell transplantation for rheumatoid arthritis–Australian experience. J Rheumatol 64:8–12

    CAS  Google Scholar 

  • Moore J, Snowden J, Pavletic S, Barr W, Burt R (2003) Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplant 32(1):S53–S56

    Article  CAS  PubMed  Google Scholar 

  • Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115(2):118–128

    Article  CAS  PubMed  Google Scholar 

  • Murrell W, Féron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G, Mackay-Sim A (2005) Multipotent stem cells from adult olfactory mucosa. Dev Dyn 233(2):496–515

    Article  PubMed  Google Scholar 

  • Nikolov NP, Pavletic SZ (2008) Technology insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Nat Clin Pract Rheumatol 4(4):184–191

    Article  PubMed  Google Scholar 

  • Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519–2529

    Article  CAS  PubMed  Google Scholar 

  • Noack M, Miossec P (2017) Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 39(4):365–383

    Article  CAS  PubMed  Google Scholar 

  • Noss EH, Brenner MB (2008) The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223(1):252–270

    Article  CAS  PubMed  Google Scholar 

  • O’Connor D (2017) Introduction to gene and stem-cell therapy. In: Molecular and cellular therapies for motor neuron diseases. Elsevier, San Diego, pp 141–165

    Chapter  Google Scholar 

  • O’Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF (1996) Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. J Rheumatol Suppl 44:72–74

    PubMed  Google Scholar 

  • O’Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 369(4):307–318

    Article  PubMed  CAS  Google Scholar 

  • Park EH, Lim H s, Lee S, Roh K, Seo KW, Kang KS, Shin K (2018) Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med 7(9):636–642

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Payab M, Goodarzi P, Foroughi Heravani N, Hadavandkhani M, Zarei Z, Falahzadeh K, Larijani B, Rahim F, Arjmand B (2018) Stem cell and obesity: current state and future perspective. Adv Exp Med Biol 1089:1–22

    Article  CAS  PubMed  Google Scholar 

  • Pedrosa M, Duarte C, Laranjeira P, Gomes J, Ribeiro T, Santos F, Antunes B, Pedreiro S, Henriques A, Martinho A, Fardilha M, Trindade H, da Silva J, Paiva A (2015) A1.10 Human bone marrow-derived mesenchymal stromal cells strongly inhibit cytokine production by naive, memory and effector CD4+ and CD8+ T cells from rheumatoid arthritis patients, independently of disease activity status. Ann Rheum Dis 74(Suppl 1):A4–A5

    Article  Google Scholar 

  • Pincus T, Castrejón I (2013) Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull NYU Hosp Jt Dis 71(suppl 1):S9

    Google Scholar 

  • Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang B-C, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9(1):181

    Article  PubMed  PubMed Central  Google Scholar 

  • Rahim F, Arjmand B, Shirbandi K, Payab M, Larijani B (2018) Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. Stem Cell Investig 5:40

    CAS  PubMed  PubMed Central  Google Scholar 

  • Scherer HU, Häupl T, Burmester GR (2020) The etiology of rheumatoid arthritis. J Autoimmun 110:102400

    Article  CAS  PubMed  Google Scholar 

  • Schett G, Emery P, Tanaka Y, Burmester G, Pisetsky DS, Naredo E, Fautrel B, van Vollenhoven R (2016) Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis 75(8):1428–1437

    Article  CAS  PubMed  Google Scholar 

  • Silva JMF, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z (2018) Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2(7):777–786

    Article  CAS  Google Scholar 

  • Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D, E. A. D. W. P. on behalf of the and P. Paediatric Diseases Working (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47(6):770–790

    Article  CAS  PubMed  Google Scholar 

  • Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421–1432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G (2017) Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol 35(2):288–295

    PubMed  Google Scholar 

  • Swann J (2011) Understanding rheumatoid arthritis: causes and treatment. Brit J Healthc Assist 5(1):15–17

    Article  Google Scholar 

  • Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435(7042):620–627

    Article  CAS  PubMed  Google Scholar 

  • Tebib JG, Boughaba H, Letroublon MC, Bienvenu J, Noel E, Armanet P, Colson F, Roullet A, Bouvier M (1991) Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression. Eur Cytokine Netw 2(4):239–243

    CAS  PubMed  Google Scholar 

  • Tedeschi SK, Frits M, Cui J, Zhang ZZ, Mahmoud T, Iannaccone C, Lin TC, Yoshida K, Weinblatt ME, Shadick NA (2017) Diet and rheumatoid arthritis symptoms: survey results from a rheumatoid arthritis registry. Arthritis Care Res 69(12):1920–1925

    Article  CAS  Google Scholar 

  • Teng Y, Verburg R, Sont J, Van den Hout W, Breedveld F, Van Laar J (2005) Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 52(8):2272–2276

    Article  CAS  PubMed  Google Scholar 

  • To K, Khan W (2019) Mesenchymal stem cell transplantation in rheumatoid arthritis. In: Stem cell transplantation for autoimmune diseases and inflammation. Springer, Cham, pp 63–74

    Chapter  Google Scholar 

  • Toes RE, Fibbe WE, Breedveld FC, van Laar JM (2002) High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol 63(8):627–637

    Article  PubMed  Google Scholar 

  • Tuan RS, Boland G, Tuli R (2002) Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5(1):32

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ueyama H, Okano T, Orita K, Mamoto K, Sobajima S, Iwaguro H, Nakamura H (2020) Local transplantation of adipose-derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis. Sci Rep 10(1):3076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Van Laar J, Tyndall A (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology 45(10):1187–1193

    Article  PubMed  Google Scholar 

  • Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 44(4):754–760

    Article  CAS  PubMed  Google Scholar 

  • Vishwakarma A, Sharpe P, Shi S, Ramalingam M (2015) Chapter 1 An introduction to stem cell biology and tissue engineering. In: Stem cell biology and tissue engineering in dental sciences. Elsevier, pp 1–13

    Google Scholar 

  • Walsh DA, McWilliams DF (2012) Pain in rheumatoid arthritis. Curr Pain Headache Rep 16(6):509–517

    Article  PubMed  Google Scholar 

  • Wang Q, Li X-F, Ma L-H, Li J-X, Chen J-W, Li F, Xue L-J, Bai J (2011) Allogenic derived mesenchymal stem cells transplantation for 4 patients with rheumatoid arthritis [J]. Chin J Allergy Clin Immunol 3

    Google Scholar 

  • Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H (2013) Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev 22(24):3192–3202

    Article  CAS  PubMed  Google Scholar 

  • Wang W, Zhou H, Liu L (2018) Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem 158:502–516

    Article  CAS  PubMed  Google Scholar 

  • Warrington KJ, Takemura S, Goronzy JJ, Weyand CM (2001) CD4+, CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 44(1):13–20

    Article  CAS  PubMed  Google Scholar 

  • Weaver A (2004) The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology 43(suppl_3):iii17–iii23

    Article  PubMed  Google Scholar 

  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253–259

    Article  CAS  PubMed  Google Scholar 

  • Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35–45

    Article  CAS  PubMed  Google Scholar 

  • Woodward WA, Chen MS, Behbod F, Rosen JM (2005) On mammary stem cells. J Cell Sci 118(16):3585–3594

    Article  CAS  PubMed  Google Scholar 

  • Wulffraat NM, De Kleer IM, Prakken B (2006) Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy. Expert Rev Mol Med 8(26):1–11

    Article  PubMed  Google Scholar 

  • Xia Y, Yin R, Fu T, Zhang L, Zhang Q, Guo G, Li L, Gu Z (2016) Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis. Patient Prefer Adherence 10:735

    PubMed  PubMed Central  Google Scholar 

  • Ye L, Li L, Wan B, Yang M, Hong J, Gu W, Wang W, Ning G (2017) Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther 8(1):90

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zeher M, Papp G, Nakken B, Szodoray P (2017) Hematopoietic stem cell transplantation in autoimmune disorders: from immune-regulatory processes to clinical implications. Autoimmun Rev 16(8):817–825

    Article  CAS  PubMed  Google Scholar 

  • Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE, I. O. F. C. I. on behalf of the and G. Bone Structure Working (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429–446

    Article  CAS  PubMed  Google Scholar 

  • Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212–215

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y, Zhang X, Xue H, Liu L, Zhu J, Jin T (2019) Autologous mesenchymal stem cell transplantation in multiple sclerosis: a meta-analysis. Stem Cells Int 2019:8536785

    PubMed  PubMed Central  Google Scholar 

Download references

Declarations

Funding: There is no financial support for this work.

Conflicts of interest/Competing interests: There is no Conflicts of/Competing interest.

Availability of data and material: Not Applicable.

Code availability: Not Applicable.

Authors’ contributions: Peyvand Parhizkar Roudsari wrote the first draft. Parisa Goodarzi , Akram Tayanloo-Beik, and Forough Azam Sayahpour helped to study and gather information, Mostafa Rezaei-Tavirani and Sepideh Alavi-Moghadam extensively edited the manuscript. Bagher Larijani participated in a critical review. Babak Arjmand helped supervise the project and gave final approval of the version to be published.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Babak Arjmand .

Editor information

Editors and Affiliations

Ethics declarations

Funding: We did not receive any funding from any institution.

Conflict of Interest: There is no conflict of interest.

Ethical Approval: This article does not contain any studies with animals and human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Roudsari, P.P. et al. (2020). The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 12. Advances in Experimental Medicine and Biology(), vol 1326. Springer, Cham. https://doi.org/10.1007/5584_2020_581

Download citation

Publish with us

Policies and ethics